6α-Methyl-17α-bromoprogesterone

6α-Methyl-17α-bromoprogesterone
Clinical data
Other names	6α-Methyl-17α-bromopregn-4-en-3,20-dione
Identifiers
PubChem CID	165360209;
CompTox Dashboard (EPA)	DTXSID101337001 ;
Chemical and physical data
Formula	C22H31BrO2
Molar mass	407.392 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C[C@H]1C[C@H]2[C@@H]3CC[C@](Br)(C(C)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CCC(=O)C=C12;
	InChI InChI=1S/C22H31BrO2/c1-13-11-16-17(20(3)8-5-15(25)12-19(13)20)6-9-21(4)18(16)7-10-22(21,23)14(2)24/h12-13,16-18H,5-11H2,1-4H3/t13-,16+,17-,18-,20?,21?,22-/m0/s1; Key:IMDRZPLSTNEVLC-RVGMEUFLSA-N;

6α-Methyl-17α-bromoprogesterone is a steroidal progestin related to haloprogesterone (6α-fluoro-17α-bromoprogesterone) that was described in 1963 and was never marketed.^[1]

References

^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 179–. ISBN 978-1-4757-2085-3.

This article about a steroid is a stub. You can help Wikipedia by expanding it.

This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.

[Elks2014-1] Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 179–. ISBN 978-1-4757-2085-3.

[1]

6α-Methyl-17α-bromoprogesterone

See also

References